CTDSPL inhibitors belong to a distinct chemical class known for their remarkable ability to modulate specific biochemical processes within cells. These inhibitors are designed to interact with and modify the activity of the CTDSPL enzyme, which plays a critical role in the regulation of various cellular functions. Through precise molecular interactions, CTDSPL inhibitors effectively hinder the catalytic function of the CTDSPL enzyme, resulting in a cascade of downstream effects that influence cellular pathways. Their mechanism of action involves binding to specific binding sites on the enzyme, thereby altering its conformation and disrupting its normal enzymatic activity.
This class of inhibitors has garnered considerable attention from researchers due to their potential to shed light on intricate cellular processes, making them valuable tools for investigating cellular signaling, gene expression, and other essential molecular mechanisms. The structural diversity of CTDSPL inhibitors allows for fine-tuning their interactions, enabling researchers to gain insights into the underlying biochemical intricacies. As our understanding of cellular processes continues to evolve, the exploration of CTDSPL inhibitors is expected to provide valuable insights into fundamental biological phenomena.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A purine derivative that inhibits CDKs (cyclin-dependent kinases) and has been shown to inhibit CTDSPL phosphatases. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Another CDK inhibitor that has been investigated for its potential to inhibit CTDSPL phosphatases. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
A naturally occurring alkaloid that has been studied for its inhibitory effects on various kinases and enzymes, including CTDSPL phosphatases. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
An antifungal antibiotic that has been shown to inhibit CTDSPL phosphatases along with other enzymes. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Originally developed as a specific inhibitor of transcription elongation, DRB also has an impact on CTDSPL phosphatases. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is a fungal metabolite calcineurin and mitochondrial permeability transition pore opening inhibitor. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
A natural compound found in blister beetles, cantharidin has been investigated for its potential inhibitory effects on CTDSPL phosphatases. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
A natural product that has been studied for its inhibitory activity against various phosphatases, including CTDSPL phosphatases. | ||||||
NSC 95397 | 93718-83-3 | sc-203654 sc-203654A | 10 mg 50 mg | $255.00 $847.00 | 9 | |
An inhibitor that has shown potential for suppressing CTDSPL phosphatase activity. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
A naturally occurring compound with reported inhibitory effects on CTDSPL phosphatases. | ||||||